Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Revance Therapeutics, Inc. - Common Stock (NQ: RVNC ) 3.090 +0.020 (+0.65%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Revance Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PWOD, RVNC, B, PSTX on Behalf of Shareholders December 18, 2024 From Halper Sadeh LLC Via GlobeNewswire REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNC December 17, 2024 From Kahn Swick & Foti, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, FLIC, RVNC on Behalf of Shareholders December 14, 2024 From Halper Sadeh LLC Via GlobeNewswire Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal August 12, 2024 Crown Laboratories will acquire Revance Therapeutics for $924 million, paying $6.66 per share — a premium of 89%. Via Benzinga Shareholder Alert: Ademi LLP Investigates Whether Revance Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders December 12, 2024 From Ademi LLP Via Business Wire 12 Health Care Stocks Moving In Monday's Pre-Market Session December 09, 2024 Via Benzinga Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement December 09, 2024 From Revance Therapeutics, Inc. Via Business Wire Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday November 12, 2024 Via Benzinga SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROIC, PWUP, RVNC on Behalf of Shareholders November 09, 2024 From Halper Sadeh LLC Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session November 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 08, 2024 Via Benzinga Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update November 07, 2024 From Revance Therapeutics, Inc. Via Business Wire PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday October 28, 2024 Via Benzinga “Top Biotech Opportunities: RVNC, HCTI, GLUE, PRSO, CRDL, Showing Promising Developments” October 28, 2024 Via AB Newswire Topics Artificial Intelligence Exposures Artificial Intelligence 12 Health Care Stocks Moving In Monday's Pre-Market Session October 28, 2024 Via Benzinga SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, ARC, K, RVNC on Behalf of Shareholders October 18, 2024 From Halper Sadeh LLC Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K, RVNC, CPTN on Behalf of Shareholders October 17, 2024 From Halper Sadeh LLC Via GlobeNewswire The Law Offices of Frank R. Cruz Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors October 17, 2024 From The Law Offices of Frank R. Cruz Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors October 15, 2024 From Law Offices of Howard G. Smith Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Revance Therapeutics, Inc. (RVNC) on Behalf of Investors October 15, 2024 From Glancy Prongay & Murray LLP Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTTR, RVNC, ARC, RFL on Behalf of Shareholders September 27, 2024 From Halper Sadeh LLC Via GlobeNewswire REVANCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Revance Therapeutics, Inc. - RVNC August 15, 2024 From Kahn Swick & Foti, LLC Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, RVNC, BALY, DRQ on Behalf of Shareholders August 13, 2024 From Halper Sadeh LLC Via GlobeNewswire Gold Gains Over 1%; Starbucks Shares Move Higher August 12, 2024 Via Benzinga Why Is Revance Therapeutics (RVNC) Stock Up 86% Today? August 12, 2024 Revance Therapeutics stock is up on Monday as RVNC investors celebrate a $924 million merger agreement with Crown Laboratories. Via InvestorPlace Crude Oil Surges 2%; B. Riley Financial Shares Plunge August 12, 2024 Via Benzinga Exposures Fossil Fuels BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Revance Therapeutics, Inc. (Nasdaq – RVNC), Greenbrook TMS, Inc. (OTC – GBNHF), R1 RCM Inc. (Nasdaq - RCM), Enstar Group Limited (Nasdaq – ESGR) August 12, 2024 From Brodsky & Smith LLC Via GlobeNewswire KE Holdings, KeyCorp, Revance Therapeutics, Starbucks And Other Big Stocks Moving Higher On Monday August 12, 2024 Via Benzinga RVNC Investigation: Halper Sadeh LLC Is Investigating Whether the Sale of Revance Therapeutics, Inc. Is Fair to Shareholders August 12, 2024 From Halper Sadeh LLC Via Business Wire Dow Dips 150 Points; Monday.com Posts Upbeat Earnings August 12, 2024 Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
